GB9818914D0 - Use - Google Patents
UseInfo
- Publication number
- GB9818914D0 GB9818914D0 GBGB9818914.5A GB9818914A GB9818914D0 GB 9818914 D0 GB9818914 D0 GB 9818914D0 GB 9818914 A GB9818914 A GB 9818914A GB 9818914 D0 GB9818914 D0 GB 9818914D0
- Authority
- GB
- United Kingdom
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9818914.5A GB9818914D0 (en) | 1998-08-28 | 1998-08-28 | Use |
| PCT/EP1999/006219 WO2000012623A2 (en) | 1998-08-28 | 1999-08-25 | Use of 5-th receptor antagonists for the treatment of parkinson's disease |
| AU59706/99A AU5970699A (en) | 1998-08-28 | 1999-08-25 | Use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9818914.5A GB9818914D0 (en) | 1998-08-28 | 1998-08-28 | Use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9818914D0 true GB9818914D0 (en) | 1998-10-21 |
Family
ID=10838073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9818914.5A Ceased GB9818914D0 (en) | 1998-08-28 | 1998-08-28 | Use |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU5970699A (en) |
| GB (1) | GB9818914D0 (en) |
| WO (1) | WO2000012623A2 (en) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU759255B2 (en) | 1998-01-29 | 2003-04-10 | Amgen, Inc. | PPAR-gamma modulators |
| US7041691B1 (en) | 1999-06-30 | 2006-05-09 | Amgen Inc. | Compounds for the modulation of PPARγ activity |
| US6586592B2 (en) | 2000-06-20 | 2003-07-01 | Pharmacia & Upjohn Company | Bis-arylsulfones |
| PE20020063A1 (en) | 2000-06-20 | 2002-01-30 | Upjohn Co | BIS-ARYLSULFONES AS LIGANDS OF THE 5-HT RECEPTOR |
| US20030171399A1 (en) | 2000-06-28 | 2003-09-11 | Tularik Inc. | Quinolinyl and benzothiazolyl modulators |
| AU2001288053A1 (en) * | 2000-09-18 | 2002-03-26 | Toa Eiyo Ltd. | N-substituted benzothiophenesulfonamide derivatives |
| US7071220B2 (en) | 2000-09-18 | 2006-07-04 | Toa Eiyo Ltd. | N-substituted benzothiophenesulfonamide derivatives |
| WO2002055013A2 (en) | 2001-01-16 | 2002-07-18 | Astrazeneca Ab | Therapeutic chromone compounds |
| IL156595A0 (en) | 2001-01-16 | 2004-01-04 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
| US7718650B2 (en) | 2001-05-11 | 2010-05-18 | Biovitrum Ab | Aryl sulfonamide compounds for treating obesity |
| NZ528450A (en) | 2001-05-11 | 2006-02-24 | Biovitrum Ab | Novel, arylsulfonamide compounds for the treatment of obesity, type II diabetes and CNS-disorders |
| ES2316619T3 (en) | 2001-08-10 | 2009-04-16 | F. Hoffmann-La Roche Ag | ARILSULFONYL DERIVATIVES WITH 5-HT RECEPTING AFFINITY 6. |
| CA2479353C (en) * | 2002-03-15 | 2010-09-14 | Toa Eiyo Ltd. | N-substituted benzothiophenesulfonamide derivative |
| US7223761B2 (en) | 2003-10-03 | 2007-05-29 | Amgen Inc. | Salts and polymorphs of a potent antidiabetic compound |
| PA8802201A1 (en) * | 2007-11-02 | 2009-06-23 | Abbott Gmbh & Co Kg | APPROPRIATE BENCENSULFONALIDE COMPOUNDS TO TREAT DISORDERS THAT RESPOND TO THE MODULATION OF SEROTONINE 5-HT6 RECEPTOR |
| AR074060A1 (en) | 2008-10-23 | 2010-12-22 | Vertex Pharma | MODULATORS OF THE TRANSMEMBRANE CHEMICAL FIBROSIS DRIVING REGULATOR |
| CA2759491A1 (en) | 2009-04-30 | 2010-11-04 | Abbott Gmbh & Co. Kg. | Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| UA107080C2 (en) | 2009-04-30 | 2014-11-25 | COMPOUNDS N-phenyl (OR HOMOPIPERAZYNIL piperazinyl) BENZOLSULFONAMIDU BENZOLSULFONILFENIL OR (OR piperazine HOMOPIPERAZYNU) suitable for the treatment of diseases that respond to modulation of 5-HT6 receptors of serotonin | |
| WO2010125136A1 (en) | 2009-04-30 | 2010-11-04 | Abbott Gmbh & Co. Kg | Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| US8343959B2 (en) | 2009-04-30 | 2013-01-01 | Abbott Gmbh & Co. Kg | N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
| WO2012059432A1 (en) | 2010-11-01 | 2012-05-10 | Abbott Gmbh & Co. Kg | N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor |
| WO2012059431A1 (en) | 2010-11-01 | 2012-05-10 | Abbott Gmbh & Co. Kg | Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor |
| CA2928537A1 (en) * | 2013-10-25 | 2015-04-30 | Glaxosmithkline Llc | Novel compounds |
| DK3448430T3 (en) * | 2016-04-26 | 2023-07-03 | H Lundbeck As | USE OF AN ACETYLCHOLINESTERASE INHIBITOR AND IDALOPIRDINE TO REDUCE FALLS IN PATIENTS WITH PARKINSON'S DISEASE |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9119932D0 (en) * | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
| US5939451A (en) * | 1996-06-28 | 1999-08-17 | Hoffmann-La Roche Inc. | Use of sulfonamides |
| DZ2376A1 (en) * | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | New sulfonamide derivatives process for their preparation and pharmaceutical compositions containing them. |
| EP0994862B1 (en) * | 1997-07-11 | 2005-06-01 | SmithKline Beecham plc | Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| GB9801392D0 (en) * | 1998-01-22 | 1998-03-18 | Smithkline Beecham Plc | Novel compounds |
-
1998
- 1998-08-28 GB GBGB9818914.5A patent/GB9818914D0/en not_active Ceased
-
1999
- 1999-08-25 WO PCT/EP1999/006219 patent/WO2000012623A2/en not_active Ceased
- 1999-08-25 AU AU59706/99A patent/AU5970699A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000012623A2 (en) | 2000-03-09 |
| AU5970699A (en) | 2000-03-21 |
| WO2000012623A3 (en) | 2000-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69924108D1 (en) | Offshore-bohrsystem | |
| DE59912303D1 (en) | Arylphenylsubstituierte cyclische ketoenole | |
| DE69918845D1 (en) | Polyketonlösung | |
| DE69913545D1 (en) | Pyrimidonderivate | |
| IL139145A0 (en) | New use | |
| EA199900308A3 (en) | Swichgear | |
| DE69943409D1 (en) | Fmcw-radar | |
| DE69904335D1 (en) | Aminomethylcarbonsäurederivate | |
| DE69940558D1 (en) | Fluoromonomerpolymerisation | |
| DE69914921D1 (en) | Phenyl-xanthinderivate | |
| DE69835235D1 (en) | Thermoplastische silikonelastomere | |
| GB9818914D0 (en) | Use | |
| DE69908871D1 (en) | Thermisch härtbare glasplatte | |
| DE59914151D1 (en) | Arylalkanoylpyridazine | |
| DE69934603D1 (en) | Elektrophotographischer photoconduktor | |
| GB9814640D0 (en) | New use | |
| DE69915628D1 (en) | Ritonavir-polymorph | |
| DE60042897D1 (en) | Photovervielfacherröhre | |
| DE69938146D1 (en) | Ptc-chip-thermistor | |
| DE69939823D1 (en) | Endo-beta-n-acetylglukosaminidase | |
| DE69905001D1 (en) | Koagulationsvorrichtung | |
| DE59904407D1 (en) | Chromanderivate | |
| EP1059091A4 (en) | Transmucous sorbefacients | |
| EP1083910A4 (en) | nrdE | |
| DE69821502D1 (en) | Boroskop |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |